FOXP3 and type 1 diabetes mellitus: Intestinal DCs are crucial to drive T cell differentiation towards an effector (Th1/Th17 cells) or regulatory (FoxP3+ Treg cells) phenotype, so VSL#3 may prevent T1D by reducing the inflammatory milieu and favoring differentiation of antigen-presenting cells (APCs) with tolerogenic function.